NTRK gene aberrations in triple‐negative breast cancer: detection challenges using IHC, FISH, RT‐PCR, and NGS

Triple‐negative breast cancer (TNBC) is usually an aggressive disease with a poor prognosis and limited treatment options. The neurotrophic tyrosine receptor kinase (NTRK) gene fusions are cancer type‐agnostic emerging biomarkers approved by the Food and Drug Administration (FDA), USA, for the selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zito Marino, Federica, Buono, Simona, Montella, Marco, Giannatiempo, Rosa, Messina, Francesco, Casaretta, Giovanni, Arpino, Grazia, Vita, Giulia, Fiorentino, Francesco, Insabato, Luigi, Sgambato, Alessandro, Orditura, Michele, Franco, Renato, Accardo, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397374/
https://www.ncbi.nlm.nih.gov/pubmed/37143440
http://dx.doi.org/10.1002/cjp2.324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397374/
https://www.ncbi.nlm.nih.gov/pubmed/37143440
http://dx.doi.org/10.1002/cjp2.324

Ejemplares similares